You are here:

  1. Home

Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template

  • NICE process and methods
  • Reference number: PMG24
  • Published:  08 January 2015
  • Last updated:  03 December 2024
  • Process
  • Tools and resources
Download (PDF)
  • Overview
  • Instructions for companies
  • 1 Decision problem, description of the technology and clinical care pathway
  • 2 Clinical effectiveness
  • 3 Cost effectiveness
  • 4 References
  • 5 Appendices
  • Appendix A: Summary of product characteristics (SmPC) and UK public assessment report
  • Appendix B: Identification, selection and synthesis of clinical evidence
  • Appendix C: Subgroup analysis
  • Appendix D: Adverse reactions
  • Appendix E: Published cost-effectiveness studies
  • Appendix F: Health-related quality-of-life studies
  • Appendix G: Cost and healthcare resource identification, measurement and valuation
  • Appendix H: Clinical outcomes and disaggregated results from the model
  • Appendix I: Price details of treatments included in the submission
  • Update information

Appendix C: Subgroup analysis

Provide a summary of the results for the subgroups in appendix C.

See section 2.8 for full details of the information required here.


Next page Appendix D: Adverse reactions Previous page Appendix B: Identification, selection and synthesis of clinical evidence
Back to top